|
|
Gubra A/S
CPH •
Healthcare •
Biotechnology •
Quote as of 06/08/2026 11:19
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCPH
Market Capitalization5,536.9 mln
Float6.28 mln
Earnings Date08/20/2026
P / E
3.24
Deeply undervalued
1-Year Forecast
452
Strong upside
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS103
P/E3.24
ROE180
RPS160
ROIC772
ROA105
Interest Cover317
EBITDA, mln2,161
EV / EBITDA2.17
EV / EBIT2.17
Revenue, mln2,637
EV / Revenue1.77
Financial Strength
Altman Z-Score29.41
Piotroski F-Score
8
/ 9
Beneish M-Score4.41
Price to Graham Number0.85
1-Year Target Price452
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-6.27% |
8
/ 100
 |
| 1 Month |
3.4% |
73
/ 100
 |
| 2 Months |
-0.3% |
36
/ 100
 |
| 6 Months |
-32.41% |
5
/ 100
|
| 1 Year |
-2.69% |
25
/ 100
 |
|
| |
